GlassScriptPhysician profile
Alexander S Roka
NPI 1982602264
$21,342.05
in general payments reported to CMS, 2019-2025
79 companies · $2,827 in 2025
The $2,827 reported for 2025 was more than what 98% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,494 · 2020: $3,164 · 2021: $3,587 · 2022: $2,538 · 2023: $2,784 · 2024: $2,948 · 2025: $2,827.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,559.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,558.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,380.93 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Abbvie INC. | $2,357.89 | 2019-2025 | Vraylar, Ubrelvy, Synthroid |
| Lilly USA, LLC | $2,101.86 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $1,754.08 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $1,441.57 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Pfizer INC. | $948.96 | 2019-2025 | |
| Amgen INC. | $942.81 | 2019-2025 | Repatha, Otezla, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $816.24 | 2022-2025 | |
| Antares Pharma, INC. | $728.08 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Janssen Pharmaceuticals, INC | $626.70 | 2019-2021 | |
| Allergan, INC. | $601.13 | 2019-2020 | |
| Amarin Pharma, INC. | $521.27 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $488.37 | 2020-2025 | Xifaxan, Cycloset |
| Boehringer Ingelheim Pharmaceuticals, INC. | $446.12 | 2019-2025 | Jardiance, Synjardy |
| Teva Pharmaceuticals USA, INC. | $380.69 | 2019-2022 |
Show all 79 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $361.69 | 2021-2025 | Zoryve, Livalo, Seglentis |
| Esperion Therapeutics, INC. | $332.86 | 2020-2023 | Nexletol |
| Takeda Pharmaceuticals U.S.A., INC. | $315.07 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $303.30 | 2019-2025 | Gardasil 9, Gardasil, Capvaxive |
| Horizon Therapeutics Plc | $260.59 | 2019-2023 | Krystexxa |
| Revance Therapeutics, INC. | $259.32 | 2025 | Daxi, Daxxify |
| Abbott Laboratories | $234.81 | 2019-2025 | Proclaim, Freestyle Libre 3, Freestyle Libre 2 |
| Idorsia Pharmaceuticals US INC | $194.28 | 2022-2024 | Quviviq |
| Sanofi-Aventis U.S. LLC | $153.60 | 2019-2022 | |
| Bausch Health US, LLC | $138.80 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $110.84 | 2019-2025 | |
| Eisai INC. | $109.01 | 2020-2021 | |
| Ardelyx, INC. | $101.81 | 2024-2025 | Ibsrela |
| Otsuka America Pharmaceutical, INC. | $88.32 | 2023-2025 | Nuedexta, Rexulti, Abilify Maintena |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $77.59 | 2024-2025 | Caplyta |
| Astellas Pharma US INC | $76.85 | 2019 | |
| Corcept Therapeutics | $76.58 | 2021-2025 | Korlym |
| Dexcom, INC. | $75.11 | 2024-2025 | Dexcom G6 Transmitter |
| Nalpropion Pharmaceuticals LLC | $69.55 | 2019 | |
| Gilead Sciences, INC. | $68.91 | 2019 | |
| Genentech USA, INC. | $67.51 | 2019-2020 | |
| Axsome Therapeutics, INC. | $67.39 | 2023-2024 | Sunosi, Auvelity |
| Azurity Pharmaceuticals, INC. | $63.55 | 2023-2025 | Edarbi, Horizant, Edarbi |
| Phathom Pharmaceuticals, INC. | $57.01 | 2024-2025 | Voquezna |
| Althera Pharmaceuticals LLC | $55.38 | 2021-2022 | |
| Biotronik INC. | $54.64 | 2024 | Orsiro Mission |
| Ironwood Pharmaceuticals, INC | $53.03 | 2020 | |
| Exact Sciences Corporation | $52.09 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Mannkind Corporation | $51.29 | 2023-2024 | Afrezza |
| Ironshore Pharmaceuticals INC. | $50.98 | 2019-2020 | |
| Acerus Pharmaceuticals Corporation | $46.53 | 2021-2022 | |
| Tolmar, INC. | $46.37 | 2025 | Jatenzo |
| Alk-Abello, INC | $44.18 | 2024 | Grastek, Ragwitek, Odactra |
| Supernus Pharmaceuticals, INC. | $42.81 | 2023 | Qelbree, Xyosted, Tlando |
| Aytu Biopharma, INC. | $41.33 | 2020 | |
| Inspire Medical Systems, INC. | $34.03 | 2025 | Inspire |
| Arbor Pharmaceuticals, INC. | $31.66 | 2019-2021 | |
| Medtronic, INC. | $31.63 | 2021-2025 | Inceptiv |
| Sumitomo Pharma America, INC. | $31.44 | 2024-2025 | Gemtesa |
| Upsher-Smith Laboratories LLC | $31.39 | 2020-2021 | |
| Halozyme INC | $30.25 | 2023 | |
| Scilex Pharmaceuticals INC. | $29.80 | 2019 | |
| Currax Pharmaceuticals LLC | $28.01 | 2022-2023 | Onzetra Xsail |
| Adlon Therapeutics L.P. | $25.32 | 2019-2021 | |
| Radius Health, INC. | $23.96 | 2022 | |
| Corium, LLC | $22.89 | 2022 | |
| Almatica Pharma LLC | $21.99 | 2024 | Loreev Xr |
| Boston Scientific Corporation | $20.75 | 2024 | Watchman Flx |
| Biohaven Pharmaceuticals, INC. | $19.68 | 2021 | |
| Lupin INC. | $18.43 | 2021 | |
| Lundbeck LLC | $18.25 | 2025 | Rexulti |
| Emd Serono, INC. | $16.96 | 2020 | |
| Clarus Therapeutics INC. | $16.08 | 2021 | |
| Alnylam Pharmaceuticals INC. | $15.96 | 2021 | |
| Vistapharm, INC. | $15.00 | 2021 | |
| Medtronic Vascular, INC. | $14.54 | 2019 | |
| Shield Therapeutics INC | $14.21 | 2024 | |
| Shire North American Group INC | $14.09 | 2019 | |
| Avanir Pharmaceuticals, INC. | $13.93 | 2019 | |
| Smith+Nephew, INC. | $13.40 | 2021 | |
| Optinose US, INC. | $12.55 | 2019 | |
| Neuronetics, INC. | $12.30 | 2023 | Neurostar Tms Therapy System |
| Pernix Therapeutics Holdings, INC. | $12.27 | 2019 | |
| Ibsa Pharma INC. | $11.60 | 2021 |
Drugs and devices associated with these payments
Vraylar $1,017Kerendia $743Mounjaro $673Jardiance $594Farxiga $571Repatha $548Trelegy Ellipta $541Otezla $488Breztri $418Wegovy $407Airsupra $348Ozempic $275Rybelsus $248Ubrelvy $227Nurtec Odt $166Arexvy $165Eliquis $164Qulipta $145Krystexxa $143Daxi $143Xyosted $134Quviviq $118Daxxify $117Tlando $105Zepbound $103Ibsrela $102Synthroid $93.68Shingrix $89.92Zoryve $85.88Livalo $80.06Caplyta $77.59Dexcom G6 Transmitter $75.11Xifaxan $74.45Nocdurna $74.33Saxenda $73.86Seglentis $65.06Proclaim $63.65Korlym $58.55Synjardy $58.13Voquezna $57.01Rexulti $55.65Orsiro Mission $54.64Afrezza $51.29Nuedexta $50.92Edarbi $48.89Jatenzo $46.37Freestyle Libre 3 $45.92Odactra $44.18Grastek $44.18Ragwitek $44.18Qelbree $42.81Sunosi $42.09Leqvio $38.37Cologuard Collection Kit $34.33Inspire $34.03Emgality $32.65Zavzpret $31.56Gemtesa $31.44Gardasil 9 $30.94Paxlovid $30.41Nexletol $27.53Auvelity $25.30Linzess $22.94Loreev Xr $21.99Watchman Flx $20.75Abilify Maintena $19.33The Cologuard Plus Collection Kit $17.76Freestyle Libre 2 $17.41Gardasil $16.66Onzetra Xsail $16.00Inceptiv $15.85Horizant $14.66Capvaxive $14.28Accrufer $14.21Cycloset $12.71Neurostar Tms Therapy System $12.30
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Roka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.